Perspectives for personalized therapy for patients with multidrug-resistant tuberculosis

Area of Science:

• Medicine
• Microbiology
• Public Health

Background:

• Tuberculosis (TB) remains a leading cause of death globally from a single pathogen.
• The rise of drug-resistant Mycobacterium tuberculosis strains, particularly multidrug-resistant TB (MDR-TB), poses a significant challenge to global control efforts.
• MDR-TB cases have seen a concerning annual increase of over 20% in recent years, reaching historical peaks.

Purpose of the Study:

• To highlight the challenges in managing MDR-TB, including diagnosis, treatment regimens, and adverse events.
• To explore the potential of personalized treatment approaches in improving outcomes for MDR-TB patients.
• To emphasize the need to implement advanced treatment strategies for MDR-TB in high-burden regions.

Main Methods:

• This study is a review and synthesis of current knowledge on MDR-TB management and treatment advancements.
• It analyzes the implications of drug resistance in Mycobacterium tuberculosis.
• It discusses the impact of personalized medicine on patient outcomes.

Main Results:

• MDR-TB management is often hindered by delayed diagnosis, uncertain drug resistance profiles, suboptimal regimens, prolonged treatment, and frequent adverse events, leading to poor prognoses.
• Recent scientific and technological progress enables the development of tailored treatment regimens.
• Personalized treatment strategies have shown significant positive implications for MDR-TB patient outcomes where implemented.

Conclusions:

• The increasing prevalence and complex management of MDR-TB necessitate innovative therapeutic strategies.
• Personalized medicine represents a promising advancement in improving treatment success rates for MDR-TB.
• Equitable access to these advanced, individualized treatments is crucial for effectively combating the MDR-TB epidemic worldwide.